- FILM COATED TABLETS
- PER OS
- AMGEN EUROPE B.V., NETHERLANDS
- Treatment of secondary hyperparathyrodism (HPT) in patients with end-dtage renal disease (ESRD) on maintenance dialysis therapy. Mimpara may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma.
- Ministry of Health - State of Israel